The Surrogate Market: How America is Commoditizing the Body

The commercialisation of surrogacy in the United States has reached unprecedented levels, with women offering their wombs as a service for thousands of dollars. Advertisements for egg donors appear increasingly online rather than on university bulletin boards, reflecting a shift in how reproductive services are marketed. These ads often list prices ranging from $10,000 upwards, with some cases involving significantly higher sums. Prospective mothers are frequently required to present academic achievements, physical fitness, or even notable accomplishments such as graduating from Harvard University to justify their value. This trend underscores the extent to which reproductive medicine has evolved into a commercial enterprise within the country. Surrogacy agencies now offer extensive profiles of potential candidates, catering not only to egg donors but also to gestational carriers willing to carry children for others. Legal firms draft contracts, while clinics implant genetically tested fertilized eggs into surrogate mothers. Some institutions have openly advertised their involvement in the creation of thousands of children, highlighting the scale of this industry. The lack of uniform legal regulation means each state determines its own policies regarding surrogacy, including whether compensation for pregnancy is allowed. While states like Louisiana impose strict limitations, California has emerged as a hub for reproductive services, attracting both domestic and international clients. California's courts have long recognized the rights of intended parents, regardless of marital status or sexual orientation, granting them parental rights even before birth. This legal framework allows surrogacy to flourish, with minimal state interference once formal requirements are met. Typically, agreements are established either through court order or contract, ensuring the intended parents are legally acknowledged as the child’s parents from birth. However, situations differ when the surrogate uses her own eggs, known as genetic surrogacy, where she may retain certain rights over the child. Most surrogacy arrangements today involve gestational surrogacy, where the embryo comes from a donor. There is no federal law prohibiting the selection of surrogates based on appearance, education, or ethnicity, nor is there legislation preventing the use of preimplantation genetic diagnosis to screen embryos. Many agencies and clinics explicitly promote these practices, framing them as expressions of reproductive autonomy. Critics, however, argue that such choices reflect eugenics-like tendencies, prioritizing specific traits over individual worth. Data on surrogacy remains scarce due to the absence of a national registry. Industry estimates suggest at least 4,000 births occurred via surrogacy last year. Information on income, occupation, race, motivation, and health outcomes is not systematically collected. Nevertheless, economic disparities are evident: surrogates typically earn around $60,000, a substantial sum for many individuals, while intended parents often possess the financial resources necessary to cover the total cost of the process, which can exceed $100,000. Recent years have seen some states implement stricter protections for surrogates and egg donors. For example, Connecticut requires surrogates to have given birth previously, undergo medical and psychological evaluations, and secure independent legal representation. These measures aim to safeguard participants' well-being and ensure informed consent. As regulatory frameworks continue to evolve, the ethical and social implications of commodifying reproduction remain a subject of ongoing debate.